Indian Semaglutide Exporters: Complete Supplier Ranking with Market Share — 255 Manufacturers (2026) — TransData Nexus

Q: Who is the largest semaglutide buyer importing from India?

ZAPATERO INTERNATIONAL LTD (MAURITIUS) is the largest semaglutide importer from India with a 10.8% market share and import value of $534.4K.

Q: How many semaglutide buyers import from India?

There are 255 active semaglutide buyers importing from India, with a combined import market of $5.0M across 2,503 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top semaglutide buyers from India?

The top 5 semaglutide buyers — ZAPATERO INTERNATIONAL LTD, STR INTERNATIONAL TRADING CO., LIMITED, STR INTERNATIONAL TRADING CO., LTD, REGENCY PHARMA LIMITED, ZAPATERO INTERNATIONAL LIMITED — together control 39.3% of total semaglutide import value from India.

Suresh Sormare

Semaglutide

India Pharmaceutical Trade Intelligence

$5.0M140 Suppliers69 CountriesHS 30049099

ExportsIndia → MAURITIUS25.0%India → HONG KONG17.2%

ImportsDENMARK → India$138.7B CHINA → India$3.9M

#1 Supplier: KARDI TRADING

Market Analysis: Top Importing Countries & Their Importers

1Mauritius

Mauritius emerges as the first largest importing country, achieving a total trade value of $1.2M through 281 shipments. This represents a market share of 25.0% of the total market activity, demonstrating their significant presence in the industry.

Top Importers: Mauritius has a diverse importer base, with their top importers including:

• ZAPATERO INTERNATIONAL LTD - $534.4K (43.0% of country's total business)

• REGENCY PHARMA LIMITED - $373.0K (30.0% of country's total business)

• ZAPATERO INTERNATIONAL LIMITED - $240.2K (19.3% of country's total business)

• REGENCY PHARMA LTD - $62.7K (5.0% of country's total business)

Key Insight: Mauritius demonstrates strong market positioning with an average shipment value of $4.4K, indicating premium pricing strategy compared to the market average of $2.0K.

Mauritius is a key market for Semaglutide imports, representing 25.0% of total trade value.

Primary Market

Secondary Market

2Hong Kong

Buyer Segment Analysis

TransData Nexus Semaglutide buyer market intelligence

1Buyer Segment Analysis

The importation of Semaglutide from India involves various buyer segments, each with distinct purchasing behaviors:

Distributors: Entities like ZAPATERO INTERNATIONAL LTD and REGENCY PHARMA LIMITED in Mauritius, as well as STR INTERNATIONAL TRADING CO., LIMITED in Thailand, function as intermediaries, procuring Semaglutide in bulk to supply to local pharmacies, hospitals, and clinics. Their purchasing patterns are characterized by large, regular orders to maintain a steady supply chain.

Hospital Groups: Institutions such as CALMETTE HOSPITAL in Cambodia directly import Semaglutide to meet the therapeutic needs of their patients. Their procurement is typically based on patient demand and treatment protocols, leading to consistent, albeit smaller, order volumes.

Retail Chains: Entities like MAXIM PHARMACY in Hong Kong import Semaglutide to stock their retail outlets. Their purchasing behavior is influenced by consumer demand, promotional activities, and inventory turnover rates, resulting in variable order sizes and frequencies.

Re-exporters: Companies such as EMIRATES POST COMPANY in the United Arab Emirates and BPOST INTERNATIONAL in Belgium may act as re-exporters, importing Semaglutide for redistribution to other markets. Their order patterns are influenced by international demand and trade agreements, leading to fluctuating purchase volumes.

Country-Specific Import Regulations

TransData Nexus Semaglutide buyer market intelligence

1Country-Specific Import Regulations

Mauritius

1. Drug Regulatory Authority: Mauritius Medicines Authority (MMA).

2. Import Registration Process: Importers must submit a dossier to the MMA, including product details, manufacturing information, and evidence of compliance with international standards.

3. Estimated Timeline for Registration: Approximately 6-12 months, depending on the completeness of the application and any additional requirements.

4. Import Tariff/Duty for HS 30049099: Pharmaceutical products under this HS code are typically exempt from import duties, but importers should verify current rates with the Mauritius Revenue Authority.

Hong Kong

1. Drug Regulatory Authority: Department of Health, Drug Office.

2. Import Registration Process: Importers must obtain a Certificate of Drug Registration by submitting an application with product specifications, clinical data, and manufacturing details.

3. Estimated Timeline for Registration: Approximately 6-9 months, subject to the Drug Office's review process.

4. Import Tariff/Duty for HS 30049099: Hong Kong maintains a free trade policy with no import duties on pharmaceutical products.

Thailand

1. Drug Regulatory Authority: Thai Food and Drug Administration (Thai FDA).

2. Import Registration Process: Importers must obtain a license from the Thai FDA, submit a registration application with comprehensive product information, and comply with advertising controls.

3. Estimated Timeline for Registration: The process can take several months, depending on the completeness of the application and the Thai FDA's review process.

4. Import Tariff/Duty for HS 30049099: Pharmaceutical products are generally subject to a 0% import duty, but importers should confirm with the Thai Customs Department.

Demand Drivers & Market Opportunity

TransData Nexus Semaglutide buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Semaglutide in importing countries is primarily driven by the rising prevalence of type 2 diabetes and obesity. According to the International Diabetes Federation, as of 2025, approximately 537 million adults worldwide are living with diabetes, with projections indicating a significant increase by 2030. This escalating health concern has led governments to implement healthcare programs aimed at managing and preventing diabetes, thereby increasing the demand for effective treatments like Semaglutide.

Additionally, the expansion of universal health coverage in many countries has improved access to essential medicines. The inclusion of Semaglutide in national formularies and its procurement through WHO Essential Medicines List initiatives and tender-based purchasing further bolster its market opportunity. The presence of 255 buyers across 69 countries, as per our data, underscores the global reach and growing demand for Semaglutide.

TransData Nexus Research · Government and regulatory sourcesMar 2026

Common Questions — Semaglutide Buyers & Importers

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

QWho is the largest semaglutide buyer importing from India?

Based on import volume and value, ZAPATERO INTERNATIONAL LTD (MAURITIUS) leads with $534.4K in imports and a 10.8% market share — the highest of any single semaglutide importer. STR INTERNATIONAL TRADING CO., LIMITED (THAILAND) and STR INTERNATIONAL TRADING CO., LTD (THAILAND) are the next largest buyers.

QHow many companies buy semaglutide from India?

There are 255 active semaglutide buyers importing from India, with a combined market of $5.0M across 2,503 shipments to 69 countries. The top 5 buyers hold 39.3% of total import value, while the remaining 250 buyers handle the other 60.7%.

QWhich countries import the most semaglutide from India?

The top importing countries for semaglutide from India are Mauritius (25.0%), Hong Kong (17.2%), Thailand (16.7%), Laos (6.4%), Botswana (4.8%). These markets represent the largest demand centres for Indian pharmaceutical exports of semaglutide, with buyers ranging from government procurement agencies to private pharmaceutical distributors.

Buyer Segment Analysis

TransData Nexus Semaglutide buyer market intelligence

1Buyer Segment Analysis

The importation of Semaglutide from India involves various buyer segments, each with distinct purchasing behaviors:

Distributors: Entities like ZAPATERO INTERNATIONAL LTD and REGENCY PHARMA LIMITED in Mauritius, as well as STR INTERNATIONAL TRADING CO., LIMITED in Thailand, function as intermediaries, procuring Semaglutide in bulk to supply to local pharmacies, hospitals, and clinics. Their purchasing patterns are characterized by large, regular orders to maintain a steady supply chain.

Hospital Groups: Institutions such as CALMETTE HOSPITAL in Cambodia directly import Semaglutide to meet the therapeutic needs of their patients. Their procurement is typically based on patient demand and treatment protocols, leading to consistent, albeit smaller, order volumes.

Retail Chains: Entities like MAXIM PHARMACY in Hong Kong import Semaglutide to stock their retail outlets. Their purchasing behavior is influenced by consumer demand, promotional activities, and inventory turnover rates, resulting in variable order sizes and frequencies.

Re-exporters: Companies such as EMIRATES POST COMPANY in the United Arab Emirates and BPOST INTERNATIONAL in Belgium may act as re-exporters, importing Semaglutide for redistribution to other markets. Their order patterns are influenced by international demand and trade agreements, leading to fluctuating purchase volumes.

Country-Specific Import Regulations

TransData Nexus Semaglutide buyer market intelligence

1Country-Specific Import Regulations

Mauritius

1. Drug Regulatory Authority: Mauritius Medicines Authority (MMA).

2. Import Registration Process: Importers must submit a dossier to the MMA, including product details, manufacturing information, and evidence of compliance with international standards.

3. Estimated Timeline for Registration: Approximately 6-12 months, depending on the completeness of the application and any additional requirements.

Hong Kong

1. Drug Regulatory Authority: Department of Health, Drug Office.

2. Import Registration Process: Importers must obtain a Certificate of Drug Registration by submitting an application with product specifications, clinical data, and manufacturing details.

3. Estimated Timeline for Registration: Approximately 6-9 months, subject to the Drug Office's review process.

4. Import Tariff/Duty for HS 30049099: Hong Kong maintains a free trade policy with no import duties on pharmaceutical products.

Thailand

1. Drug Regulatory Authority: Thai Food and Drug Administration (Thai FDA).

2. Import Registration Process: Importers must obtain a license from the Thai FDA, submit a registration application with comprehensive product information, and comply with advertising controls.

3. Estimated Timeline for Registration: The process can take several months, depending on the completeness of the application and the Thai FDA's review process.

4. Import Tariff/Duty for HS 30049099: Pharmaceutical products are generally subject to a 0% import duty, but importers should confirm with the Thai Customs Department.

Demand Drivers & Market Opportunity

TransData Nexus Semaglutide buyer market intelligence

1Demand Drivers & Market Opportunity

TransData Nexus Research · Government and regulatory sourcesMar 2026

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Semaglutide

Semaglutide

Who Buys Semaglutide from India — 255 Importers Behind a $5.0M Market

Top Semaglutide Importers — Ranked by Import Value

Top Semaglutide Buyers & Importers

Related Analysis

Need Details?

Market Analysis: Top Importing Countries & Importers

Which companies are buying Semaglutide — and from which countries?

Semaglutide — Buyer Countries to Key Importers

Market Analysis: Top Importing Countries & Their Importers

1Mauritius

2Hong Kong

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Common Questions — Semaglutide Buyers & Importers

QWho is the largest semaglutide buyer importing from India?

QHow many companies buy semaglutide from India?

QWhich countries import the most semaglutide from India?

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

3Thailand

4Laos

5Botswana

QWhat is the average import order value for semaglutide from India?

Analysis Methodology